State of Tennessee, Department of Treasury

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1587973 NASHVILLE, TN

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,791,269

+$335,766 QoQ

Shares Held

22,771

-2.3% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#130

of 341 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

State of Tennessee, Department of Treasury holds $144,818,259 across 31 Biotechnology names. PTGX ranks #15 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	93,032	$46,211,785
2	REGN	Regeneron Pharmaceuticals, Inc.	46,766	$29,160,471
3	ROIV	Roivant Sciences Ltd.	181,244	$6,414,225
4	JAZZ	Jazz Pharmaceuticals plc	24,074	$5,801,111
5	CYTK	Cytokinetics Inc	60,194	$5,127,926
6	MRNA	Moderna, Inc.	67,822	$4,749,574
7	BMRN	Biomarin Pharmaceutical Inc	81,548	$4,666,176
8	HALO	Halozyme Therapeutics, Inc.	56,499	$4,422,176

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,791,269	22,771	-2.3%	Shares	Sole	2026-08-14
2026-03-31	$2,455,503	23,297	-1.0%	Shares	Sole	2026-05-15
2025-12-31	$2,054,760	23,526	-11.2%	Shares	Sole	2026-02-18
2025-09-30	$1,759,730	26,490	+1.9%	Shares	Sole	2025-11-14
2025-06-30	$1,436,467	25,990	-1.9%	Shares	Sole	2025-08-15
2025-03-31	$1,280,814	26,485	-2.2%	Shares	Sole	2025-05-13
2024-12-31	$1,045,133	27,076	-2.4%	Shares	Sole	2025-02-13
2024-09-30	$1,248,435	27,743	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.